AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Revolution Medicines at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Revolution Medicines brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 528. Its sessions centre on RAS-driven cancer, tracing a mutation into a targeted drug class, and on molecular diagnostics for pancreatic lesions that are hard to see and harder to treat. The company develops oral RAS inhibitors.
| Organization | AMP 2026 Attendance |
|---|---|
Revolution Medicines Redwood City, CA | |
Oncology company developing oral RAS(ON) inhibitors for patients with RAS-addicted cancers. | Booth Exhibiting at Booth 528 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 3:00pm–3:50pm RAS in ACTION - From A Single Mutation to a Targeted Class RAS mutation testing across lung, colorectal and pancreatic cancers, with tissue and liquid biopsy considerations for targeted therapy. Workshop Thu, Nov 12 4:25pm–4:55pm It's Hard to Treat What You Can't See: Leveraging Molecular Diagnostics to Improve Care of Patients with Pancreatic Lesions Pancreatic lesions are hard to call on imaging and cytology alone; molecular testing can sharpen diagnosis and risk stratification. |
Find decision makers at Revolution Medicines
Tell us what you sell and we’ll find the people at Revolution Medicines most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction